Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS HostedCardiovascular news
'Game-changing' new cholesterol-lowering drug to be given by GPs
Draft guidance from NICE recommends inclisiran (Leqvio)...
Irbesartan batches recalled over contamination
Batches of some irbesartan-containing products are...
Second SGLT2 inhibitor approved for heart failure
Clinicians now have a choice of SGLT2 inhibitors to...
New research supports statin prescribing in patients over 75 years
Evidence suggesting a mortality benefit of statins...
Prescribe antihypertensives to reduce cardiovascular risk regardless of blood pressure, say researchers
Prescribers should consider blood pressure-lowering...
Updated NICE atrial fibrillation guidance recommends newer anticoagulants
Direct-acting oral coagulants should be offered to...
New oral lipid-lowering treatment approved by NICE
Bempedoic acid (Nilemdo) has been approved for routine...
'Innovative' heart failure treatment recommended by NICE
Dapagliflozin (Forxiga), the first SGLT2 inhibitor...
New lipid-lowering treatment available to prescribe
Bempedoic acid (Nilemdo) is a new oral treatment option...
Most statin side-effects down to 'nocebo' effect, study suggests
90% of the symptom burden reported with statins was...
Diabetes drug approved to treat heart failure
Forxiga (dapagliflozin) is the first SGLT2 inhibitor...
MHRA urges GPs to ensure continued INR monitoring during pandemic
The MHRA advice was issued following reports of an...
New MIMS table to guide antihypertensive monitoring in primary care
Monitoring requirements for ACE inhibitors and angiotensin...
Statin prescribing 'commonly breaching NICE guidance'
Prescribing of suboptimal statin regimens is 'extremely...
Stopping antihypertensives in elderly may be safe
Discontinuing antihypertensive medication in older...
Quadruple therapy should be 'new therapeutic standard' for heart failure, say researchers
Treatment with a four-drug regimen incorporating newer...
'No convincing alternative' to aspirin for secondary cardiovascular prevention, meta-analysis suggests
In a meta-analysis of randomised trials, patients who...
GPs overestimate benefits and harms of treatments, say researchers
GPs’ knowledge of the absolute benefits and harms of...
Omega-3 supplements withdrawn from secondary prevention use
Omega-3 fatty acids can no longer be prescribed to...
Thiazides better than ACE inhibitors as first-line antihypertensives, large-scale analysis suggests
Thiazide diuretics are more effective than ACE inhibitors...